Abstract
Conventional secondary antibodies for immunoassays are generally obtained from live animals or expensive mammalian cell culture systems. These antibodies are then conjugated with enzymes that repeatedly convert inactive substrates to signal-generating active products by secondary antibody mimics of low-abundance target molecules in a concentration-dependent manner. In this study, we constructed recombinant immunoglobulin G (IgG)-binding nanobody-based secondary antibody mimics using a well-established SpyTag/SpyCatcher protein ligation system. We prepared SpyCatcher as a scaffold protein, chemically conjugated it with an activated horseradish peroxidase (HRP), and fused SpyTag to two IgG-binding nanobodies specific for the Fc regions of mouse IgG1 and rabbit IgG, which is denoted as MG1Nb and RNb, respectively. We selectively ligated HRP-conjugated SpyCatcher with SpyTag-fused MG1Nb or RNb depending on the original species of primary antibodies and amplified signals of target molecules in a plug-and-playable manner. We successfully demonstrated that HRP:MG1Nb and HRP:RNb selectively bind to target-bound mouse IgG1 or rabbit IgG, respectively, and serve as excellent target-specific signal amplifiers in various immunoassays such as western blot, enzyme-linked immunosorbent assay (ELISA), and multiplex tyramide signal amplification (TSA) cell and tissue imaging. These recombinant signal-amplifying IgG-binders can be simple and reliable alternatives to conventional secondary antibodies in various immunoassays.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.